|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DYN | Cox John | Officer | Dec 05 '25 | Proposed Sale | 20.72 | 2,662 | 55,150 | Dec 05 04:55 PM | |
| DYN | Cox John | CEO & President | Dec 05 '25 | Sale | 20.72 | 2,662 | 55,157 | 196,877 | Dec 05 04:11 PM |
| DYN | Cox John | CEO & President | Sep 05 '25 | Sale | 13.41 | 2,640 | 35,402 | 199,539 | Sep 09 04:31 PM |
| DYN | Cox John | Officer | Sep 05 '25 | Proposed Sale | 13.41 | 2,640 | 35,404 | Sep 05 04:14 PM | |
| DYN | Cox John | CEO & President | Jul 14 '25 | Buy | 9.11 | 100,000 | 911,000 | 242,179 | Jul 15 05:11 PM |
| DYN | Cox John | CEO & President | Jun 05 '25 | Sale | 13.35 | 4,060 | 54,201 | 142,179 | Jun 06 04:07 PM |
| DYN | Cox John | Officer | Jun 05 '25 | Proposed Sale | 13.35 | 4,060 | 54,186 | Jun 05 04:11 PM | |
| DYN | Cox John | CEO & President | Mar 05 '25 | Sale | 11.83 | 4,061 | 48,042 | 146,239 | Mar 07 04:07 PM |
| DYN | Cox John | Officer | Mar 05 '25 | Proposed Sale | 11.89 | 4,067 | 48,356 | Mar 05 04:09 PM | |
| DYN | Cox John | CEO & President | Sep 04 '24 | Buy | 33.04 | 32,000 | 1,057,216 | 8,000 | Sep 04 05:42 PM |
| RGEN | Cox John | Director | Mar 24 '20 | Sale | 96.72 | 1,858 | 179,706 | 923 | Mar 26 07:31 PM |
| RGEN | Cox John | Director | Mar 18 '20 | Option Exercise | 24.37 | 26,736 | 651,603 | 29,517 | Mar 20 04:25 PM |
| RGEN | Cox John | Director | Mar 18 '20 | Sale | 95.27 | 26,736 | 2,547,035 | 2,781 | Mar 20 04:25 PM |
| RGEN | Cox John | Director | Mar 04 '20 | Option Exercise | 12.91 | 10,000 | 129,100 | 12,781 | Mar 05 05:52 PM |
| RGEN | Cox John | Director | Mar 04 '20 | Sale | 93.39 | 10,000 | 933,900 | 2,781 | Mar 05 05:52 PM |
| RGEN | Cox John | Director | Feb 24 '20 | Sale | 92.81 | 4,455 | 413,455 | 2,781 | Feb 26 04:27 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 08 '16 | Option Exercise | 0.00 | 4,026 | 0 | 29,666 | Feb 09 04:51 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Mar 25 '15 | Option Exercise | 65.85 | 5,066 | 333,571 | 37,577 | Mar 26 04:31 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Mar 25 '15 | Sale | 449.06 | 12,010 | 5,393,211 | 25,567 | Mar 26 04:31 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 12 '15 | Option Exercise | 0.00 | 3,738 | 0 | 33,214 | Feb 17 08:40 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 08 '15 | Option Exercise | 0.00 | 4,023 | 0 | 29,590 | Feb 10 05:07 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 09 '15 | Option Exercise | 0.00 | 4,691 | 0 | 32,744 | Feb 10 05:07 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 23 '14 | Option Exercise | 0.00 | 2,598 | 0 | 26,706 | Feb 25 02:17 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 12 '14 | Option Exercise | 0.00 | 2,246 | 0 | 25,167 | Feb 14 04:34 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 08 '14 | Option Exercise | 0.00 | 4,023 | 0 | 21,883 | Feb 11 06:07 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 09 '14 | Option Exercise | 0.00 | 4,691 | 0 | 25,133 | Feb 11 06:07 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 23 '13 | Option Exercise | 0.00 | 2,598 | 0 | 19,986 | Feb 26 01:26 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 08 '13 | Option Exercise | 0.00 | 3,487 | 0 | 15,665 | Feb 12 05:10 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 09 '13 | Option Exercise | 0.00 | 4,692 | 0 | 19,224 | Feb 12 05:10 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 23 '12 | Option Exercise | 0.00 | 2,600 | 0 | 15,376 | Feb 27 04:19 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 09 '12 | Option Exercise | 0.00 | 4,692 | 0 | 14,280 | Feb 13 04:28 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Nov 01 '11 | Option Exercise | 72.87 | 2,175 | 158,492 | 11,763 | Nov 03 10:52 AM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Nov 01 '11 | Sale | 114.37 | 2,175 | 248,755 | 9,588 | Nov 03 10:52 AM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Apr 21 '11 | Option Exercise | 72.87 | 4,350 | 316,984 | 14,703 | Apr 25 02:02 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Apr 21 '11 | Sale | 100.00 | 4,350 | 435,000 | 10,353 | Apr 25 02:02 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Apr 13 '11 | Option Exercise | 56.73 | 36,234 | 2,055,646 | 46,587 | Apr 15 11:50 AM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Apr 13 '11 | Sale | 80.00 | 36,234 | 2,898,720 | 10,353 | Apr 15 11:50 AM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Apr 11 '11 | Option Exercise | 47.92 | 6,900 | 330,648 | 17,253 | Apr 13 10:14 AM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Apr 11 '11 | Sale | 78.00 | 6,900 | 538,200 | 10,353 | Apr 13 10:14 AM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Mar 31 '11 | Option Exercise | 43.50 | 2,840 | 123,540 | 12,658 | Apr 01 03:20 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Mar 31 '11 | Sale | 73.00 | 2,840 | 207,320 | 9,818 | Apr 01 03:20 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Mar 02 '11 | Sale | 70.10 | 4,041 | 283,259 | 9,818 | Mar 03 03:10 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 23 '11 | Option Exercise | 0.00 | 2,138 | 0 | 15,741 | Feb 25 03:56 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 17 '11 | Sale | 67.08 | 1,843 | 123,620 | 13,603 | Feb 18 03:06 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Nov 09 '10 | Sale | 62.87 | 773 | 48,597 | 16,356 | Nov 10 02:21 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Nov 02 '10 | Sale | 63.04 | 765 | 48,228 | 17,129 | Nov 03 01:50 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Oct 28 '10 | Option Exercise | 33.97 | 6,900 | 234,393 | 25,154 | Oct 29 02:25 PM |
| BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Oct 28 '10 | Sale | 63.00 | 6,900 | 434,700 | 18,254 | Oct 29 02:25 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite